Patent · US Active

Methods of treating advanced prostate cancer

US11541062B2 · kind B2 · utility

0Cited by
2References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 11, 2020
Grant dateJan 3, 2023
Priority date
Expiry dateFeb 21, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2300/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods for treating metastatic prostate cancer using anti-androgen compounds and radionuclide-labeled androgens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.